1.Metastatic Klebsiella Infection: A case report
Jacklyn So-Cabahug ; Jennifer Justice Manzano
Philippine Journal of Internal Medicine 2019;57(1):39-45
Introduction:
A new hypervirulent (hypermucoviscous) variant of Klebsiella pneumoniae (K. pnuemoniae) had emerged. It has shown ability to cause serious infection in healthy ambulatory hosts as well as infect unusual sites. Though there have been numerous studies on severe infection by K. pneumoniae, little data has been documented on such infections involving Klebsiella oxytoca. (K. oxytoca). It is capable of causing metastatic spread of the infection even in healthy young individuals. This report was written to describe the clinical spectrum of a case of metastatic Klebsiella infection.
Case presentation:
We illustrate a case of a 73-year-old diabetic and hypertensive female presenting with headache and eye discharge. She was initially managed as the case of conjunctivitis as out-patient. After three weeks of topical ophthalmic antibiotics, she developed decrease in sensorium leading to her eventual admission. Workup pointed towards a disseminated infection to the eye, brain, and urinary tract. The patient was placed on broad-spectrum antibiotics and a vitreous tap was done. However, the patient’s sensorium decreased further, and was eventually intubated and started on inotropes. The indolent course of the disease, which unfortunately led to the demise of the patient, directed the attending physicians to suspect a more virulent infection.
Discussion:
Infection by hypervirulent variant of Klebsiella has been classically known to be nosocomial and opportunistic in nature. But cases have also been reported from the community setting. A common denominator in this population is that they are usually immunocompromised as in the case of our patient being elderly and diabetic. Unfortunately, there are no molecular or biochemical markers being used in the clinical setting to identify this strain. Hence, the attending physicians had to rely on the presentation of metastatic disease to diagnose our patient.
Conclusion
Early diagnosis, appropriate antibiotic treatment and drainage are keys in the management of these cases.
Infections
2.Congenital Systemic Cytomegalic Inclusion Disease.
Dong Beom LEE ; Dong Hyun KIM ; Jung Sik MIN ; Chang Hee CHOI ; Je Geun CHI
Journal of the Korean Pediatric Society 1990;33(1):100-106
No abstract available.
Cytomegalovirus Infections*
3.Extraintestinal salmonellosis.
Sang Gyung KIM ; Young Sik CHOI ; Woong Soo LEE ; Tae Yeal CHOI ; Choon Won KIM ; Ho Won KIM
Korean Journal of Clinical Pathology 1991;11(3):627-631
No abstract available.
Salmonella Infections*
4.A case of nocardiosis.
Jeong Hee KIM ; Ki Heon YOON ; Jee Hong YOO ; Hong Mo KANG ; Jin Tae SUH
Tuberculosis and Respiratory Diseases 1992;39(4):355-360
No abstract available.
Nocardia Infections*
5.A Case of Congenital Systemic Cytomegalic Inclusion Disease.
Kong Sik KIM ; Eun Young KWAK ; Ho Seong YOO ; Sang Gi PARK ; Young Bong PARK
Journal of the Korean Pediatric Society 1990;33(2):220-224
No abstract available.
Cytomegalovirus Infections*
6.The prevention of pneumococcal infections.
Clinical and Experimental Vaccine Research 2016;5(1):3-5
No abstract available.
Pneumococcal Infections*
7.Salmonellosis.
Korean Journal of Clinical Microbiology 2001;4(1):5-10
No abstract available.
Salmonella Infections*
8.Congenital Generalized Cytomegalic Inclusion Disease.
Byung Yun CHUNG ; Jun Ho KIM ; Go Chang KIM ; Won Jae PARK
Journal of the Korean Pediatric Society 1981;24(12):1197-1202
No abstract available.
Cytomegalovirus Infections*
9.Skeletal manifestation in congenital cytomegalic inclusion disease: a case report.
Myung Sang MOON ; In Young OK ; Hee Dai LEE ; Sung Tae KIM ; Jin Tack KIM
The Journal of the Korean Orthopaedic Association 1991;26(3):982-985
No abstract available.
Cytomegalovirus Infections*
10.Pathological findings in a mouse model for Coxsackievirus A16 infection
Yuan Teng Hooi ; Kien Chai Ong ; David Perera ; Kum Thong Wong
Neurology Asia 2015;20(4):343-347
Coxsackievirus A16 (CV-A16) is the leading cause of hand-foot-mouth disease (HFMD), which usually
presents as mild and self-limiting symptoms in young children. Rarely, CV-A16 has been reported
to cause severe and fatal neurological complications but little is known about these complications.
In the present study, 1-day and 7-day old mouse models of CV-A16 were developed using a clinical
strain via subcutaneous inoculation. All infected mice exhibited clinical signs of infection, including
reduced mobility, limb weakness and paralysis between 3 to 6 days post-infection. Pathologically,
the main organs involved were the central nervous system (CNS), skeletal muscles and brown fat. In
the CNS, viral antigens as demonstrated by immunohistochemistry, were localized mainly to neurons
in the brain stem and spinal cord, suggesting that CV-A16 is neurotropic although inflammation is
very mild. The skeletal muscles showed necrosis and myositis due to viral infection as evidenced by
the dense viral antigens. Focal viral antigens were also detected in the brown fat. These preliminary
pathological findings indicate that our mouse models can be further developed to be useful models
for pathogenesis studies, and vaccine and anti-viral drug evaluation.
Coxsackievirus Infections